Anagrelide Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Anagrelide Anagrelide 3-Hydroxy Impurity VL2810006View CAS 733043-41-9
Anagrelide Anagrelide 5-Acetoxy Impurity VL2810009View CAS 1076198-71-4
Anagrelide Anagrelide 7 Dechloro Impurity VL2810010View CAS 61834-95-5
Anagrelide Anagrelide Impurity 2 HCl VE0012224View
Anagrelide Anagrelide Impurity 4 VE0012226View CAS 2187431-31-6
Anagrelide Anagrelide Open ring methyl ester VL2810004View CAS 752151-24-9
Anagrelide Anagrelide Related Compound B VL2810002View CAS 1159977-03-3
Anagrelide Anagrelide Related Compound C VL2810003View CAS 70381-75-8
Anagrelide Anagrelide Related compound A VL2810001View CAS 85325-12-8
Anagrelide Anagrelide Trichlor Derivative VL2810005View CAS 1092352-99-2

[rfq_list]

Request a quote

1076198-71-4: Anagrelide 5-Acetoxy Impurity

1076198-71-4: Anagrelide 5-Acetoxy Impurity
Catalogue No.

VL2810009
CAS No.

1076198-71-4
Molecular Formula

C12H9Cl2N3O3
Molecular Weight

314.12
Parent drug

Anagrelide
IUPAC Name

6, 7-Dichloro-1, 2, 3, 5-tetrahydro-2-oxoimidazo[2, 1, b]quinazolin-5-yl Acetate
Synonyms

N/A
References

Ito, Tomoki, et al. “Efficacy and Safety of Anagrelide as a First-Line Drug in Cytoreductive Treatment-Naïve Essential Thrombocythemia Patients in a Real-World Setting.” European Journal of Haematology, vol. 103, no. 2, 17 June 2019, pp. 116–123, 10.1111/ejh.13265.
Status

In-stock
ListName

Anagrelide 5-Acetoxy Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden